Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nolvadex Dose Response for Casodex-Induced Gynaecomastia
NCT00637871Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2002
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in gynecomastia and mastalgia comparing Casodex + Placebo with Casodex + Nolvadex (2 arms). Started Nov 2002; status: completed.
02
Drugs
tamoxifen
03
Conditions
gynecomastiamastalgia
Beyond the preview
Go deeper on NCT00637871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637871.